KANSAS CITY, Kan., May 14, 2015 /PRNewswire/ -- Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative biopharmaceutical products for companion animals, today announced that data and observational studies resulting from the Company’s extensive clinical development pipeline will be featured in multiple oral and poster presentations during the 2015 American College of Veterinary Internal Medicine Forum (ACVIM) in Indianapolis, IN. The 2015 ACVIM Forum is being held June 3-6, 2015 at the Indiana Convention Center to advance the growth and science of veterinary and animal care.
Showcasing its growing leadership in the development and commercialization of pet medications, Aratana’s advancements in the treatment of pet oncology, inappetence and pain will be the subject of 11 presentations during the 2015 ACVIM Forum. The presentations will be given by veterinary industry experts over the course of the four-day conference:
Cancer Therapies and Clinical Studies
Title: | The Evolving Science of Immunotherapeutics in Veterinary Oncology | |
Date: | Thursday, June 4, 2015 | |
Time/Type: | 10:30 am 11:20 am (Eastern Time) CE Presentation | |
Location: | Indiana Convention Center Sagamore 7 | |
Presenter: | Philip J. Bergman, DVM, Ph.D., DACVIM (Oncology); and Chad Johannes, DVM, DACVIM (SAIM, Oncology) | |
Title: | A Prospective, Open-Label Study Evaluating Treatment of Canine B-cell Lymphoma with L-Asparaginase, Doxorubicin and a Canine Anti-CD20 Monoclonal Antibody | |
Date: | Thursday, June 4, 2015 | |
Time/Type: | 11:00 am 11:15 am (Eastern Time) Abstract Presentation | |
Location: | Indiana Convention Center Room 233 | |
Presenter: | Carlos O. Rodriguez, Jr., DVM, Ph.D., DACVIM (Oncology) | |
Title: | Clinical Application of Immunotherapeutics in Veterinary Oncology | |
Date: | Thursday, June 4, 2015 | |
Time/Type: | 11:30 am 12:20 pm (Eastern Time) CE Presentation | |
Location: | Indiana Convention Center Sagamore 7 | |
Presenter: | Philip J. Bergman, DVM, Ph.D., DACVIM (Oncology); and Chad Johannes, | |
DVM, DACVIM (SAIM, Oncology) | ||
Title: | Anti-CD20 Monoclonal Antibody Canine Lymphoma Therapy: A Double-Blind, Randomized, Placebo-Controlled Study | |
Date: | Friday, June 5, 2015 | |
Time/Type: | 5:25 pm 5:50 pm (Eastern Time) Research Report Presentation | |
Location: | Indiana Convention Center Room 201 | |
Presenter: | Gregory Ogilvie, DACVIM (SAIM, Oncology), DECVIM-CA (Oncology) | |
Title: | Combination Listeria-Based Immunotherapy Plus Palliative Radiation Delays Tumor Progression and Prolongs Overall Survival in Canine Osteosarcoma | |
Date: | Saturday, June 6, 2015 | |
Time/Type: | 8:00 am (Eastern Time) Late-Breaking Abstract Presentation | |
Location: | Indiana Convention Center Room 204 | |
Presenter: | Nicola Mason, BVetMed, Ph.D., DACVIM (SAIM) |
Inappetence Solutions in Development
Title: | Safety of the Ghrelin Agonist, Capromorelin, Administered Daily to Beagle Dogs for One Year | |
Date: | Thursday, June 4, 2015 | |
Time/Type: | 10:30 am 10:45 am (Eastern Time) Abstract Presentation | |
Location: | Indiana Convention Center Room 231 | |
Presenter: | Linda Rhodes, VMD, Ph.D. | |
Title: | Capromorelin, An Orally Active Ghrelin Agonist, Caused Sustained Increases in IGF-1, Increased Food Intake and Body Weight in Cats | |
Date: | Friday, June 5, 2015 | |
Time/Type: | 6:00 pm 7:30 pm (Eastern Time) Abstract Poster Session | |
Location: | Indiana Convention Center Hall C | |
Presenter: | Bill Zollers, Ph.D. | |
Title: | Safety of the Ghrelin Agonist, Capromorelin, Administered to Cats for 91 Days at an Oral Dose of 6 mg/kg | |
Date: | Friday, June 5, 2015 | |
Time/Type: | 6:00 pm 7:30 pm (Eastern Time) Abstract Poster Session | |
Location: | Indiana Convention Center Hall C | |
Presenter: | Julie Allen, BVMS, MS, MRCVS, DACVIM (SAIM) | |
Title: | New Therapeutic Advances in Inappetence for Pets | |
Date: | Friday, June 5, 2015 | |
Time/Type: | 6:30 am 8:00 am (Eastern Time) Special Breakfast Session | |
Location: | Indiana Convention Center Room 123-124 | |
Presenter: | Audrey Cook, BVM&S, MRCVS, DACVIM, (SAIM), DECVIM (CA), DABVP |
Pain Management Treatment Advances
Title: | Introduction to the Emerging Piprant Therapeutic Class of Prostanoid Receptor Antagonists | |
Date: | Friday, June 5, 2015 | |
Time/Type: | 9:00 am 9:50 am (Eastern Time) CE Presentation | |
Location: | Indiana Convention Center Sagamore 1 | |
Presenter: | Kristin Kirkby Shaw, DVM, MS, Ph.D., DACVS, DACVSMR | |
Title: | Safety and Toxicokinetic Profiles in Cats Administered Grapiprant, A Selective Prostaglandin-Receptor Antagonist | |
Date: | Friday, June 5, 2015 | |
Time/Type: | 6:00 pm 7:30 pm (Eastern Time) Abstract Poster Session | |
Location: | Indiana Convention Center Hall C | |
Presenter: | Lesley Rausch-Derra, DVM, MS |
About Aratana Therapeutics
Aratana Therapeutics is a pet therapeutics company focused on licensing, developing and commercializing innovative biopharmaceutical products for companion animals. Aratana believes that it can leverage the investment in the human biopharmaceutical industry to bring therapeutics to pets in a capital and time efficient manner. The company’s pipeline includes therapeutic candidates targeting pain, inappetence, cancer, viral diseases, allergy and other serious medical conditions. Aratana believes the development and commercialization of these therapeutics will permit veterinarians and pet owners to manage pets’ medical needs safely and effectively, resulting in longer and improved quality of life for pets. For more information, please visit www.aratana.com.
Contacts:
For investor inquires:
Aratana Therapeutics, Inc.
Craig Tooman
ctooman@aratana.com; (913) 353-1026
For media inquiries:
Tiberend Strategic Advisors, Inc.
Andrew Mielach
amielach@tiberend.com; (212) 375-2694
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/aratana-therapeutics-to-showcase-extensive-clinical-development-pipeline-at-acvim-300083702.html
SOURCE Aratana Therapeutics, Inc.
Help employers find you! Check out all the jobs and post your resume.
